Medicines and universal health coverage: challenges and opportunities.
作者信息
Bigdeli Maryam, Laing Richard, Tomson Göran, Babar Zaheer-Ud-Din
机构信息
Alliance for Health Policy and Systems Research, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland.
Boston University School of Public Health, 801 Massachusetts Avenue, Boston, MA 02118 USA.
出版信息
J Pharm Policy Pract. 2015 Feb 16;8(1):8. doi: 10.1186/s40545-015-0028-4. eCollection 2015.
Abstract
摘要
相似文献
1
Medicines and universal health coverage: challenges and opportunities.药品与全民健康覆盖：挑战与机遇
J Pharm Policy Pract. 2015 Feb 16;8(1):8. doi: 10.1186/s40545-015-0028-4. eCollection 2015.
2
Quality use of medicines within universal health coverage: challenges and opportunities.全民健康覆盖下的合理用药：挑战与机遇
BMC Health Serv Res. 2014 Aug 27;14:357. doi: 10.1186/1472-6963-14-357.
3
Noncommunicable diseases, access to essential medicines and universal health coverage.非传染性疾病、基本药物获取和全民健康覆盖。
Glob Health Action. 2019;12(1):1670014. doi: 10.1080/16549716.2019.1670014.
4
Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.在加拿大现有公共药品计划中增加基本药物清单的全民公共覆盖的估计效果。
CMAJ. 2017 Feb 27;189(8):E295-E302. doi: 10.1503/cmaj.161082.
5
Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunities.在低收入和中等收入国家，将零售药店作为公共部门客户基本药物的来源：对关键考虑因素、挑战和机遇的范围界定审查
J Pharm Policy Pract. 2023 May 2;16(1):60. doi: 10.1186/s40545-023-00557-w.
6
Household access to non-communicable disease medicines during universal health care roll-out in Kenya: A time series analysis.肯尼亚全民医保推出期间家庭获得非传染性疾病药物的情况：时间序列分析。
PLoS One. 2022 Apr 20;17(4):e0266715. doi: 10.1371/journal.pone.0266715. eCollection 2022.
7
Essential Medicines in Universal Health Coverage: A Scoping Review of Public Health Law Interventions and How They Are Measured in Five Middle-Income Countries.全民健康覆盖中的基本药物：五项中等收入国家公共卫生法干预措施及其衡量方法的范围综述。
Int J Environ Res Public Health. 2020 Dec 18;17(24):9524. doi: 10.3390/ijerph17249524.
8
How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines: a case of Ghana.医药改革如何以及为何通过改善药品公平可及性来促进全民健康覆盖：以加纳为例。
Front Public Health. 2023 Jul 7;11:1163342. doi: 10.3389/fpubh.2023.1163342. eCollection 2023.
9
[Challenges and opportunities for the development of a national pharmaceutical policy in México].[墨西哥国家制药政策发展面临的挑战与机遇]
Salud Publica Mex. 2013 May-Jun;55(3):329-36.
10
Challenges and Opportunities for Universal Health Coverage in South Asia: A Scoping Review.南亚全民健康覆盖面临的挑战与机遇：一项范围界定综述
Asia Pac J Public Health. 2025 Jan;37(1):7-16. doi: 10.1177/10105395241296653. Epub 2024 Nov 15.
引用本文的文献
1
Tripled likelihood: polypharmacy increases the occurrence of drug therapy problems in hospitalized pediatric patients.可能性增加两倍：多重用药会增加住院儿科患者药物治疗问题的发生率。
Front Pharmacol. 2024 Apr 25;15:1375728. doi: 10.3389/fphar.2024.1375728. eCollection 2024.
2
Is the national health insurance scheme a pathway to sustained access to medicines in Nigeria?国家健康保险计划是否是尼日利亚持续获得药物的途径？
BMC Health Serv Res. 2024 Mar 29;24(1):403. doi: 10.1186/s12913-024-10827-1.
3
Effect of antibiotic medicines availability on adherence to standard treatment guidelines among hospitalized adult patients in southern Malawi.抗生素药物的可获得性对马拉维南部住院成年患者遵守标准治疗指南的影响。
PLoS One. 2023 Oct 31;18(10):e0293562. doi: 10.1371/journal.pone.0293562. eCollection 2023.
4
Explanation of Socio-economic Inequality in Medicine Use: A Cross-sectional Analysis from Iran.医疗使用中的社会经济不平等现象解析：来自伊朗的横断面分析
Iran J Pharm Res. 2022 Dec 31;21(1):e129431. doi: 10.5812/ijpr-129431. eCollection 2022 Dec.
5
Implementation of medicines pricing policies in sub-Saharan Africa: systematic review.撒哈拉以南非洲药品定价政策的实施：系统评价。
Syst Rev. 2022 Dec 1;11(1):257. doi: 10.1186/s13643-022-02114-z.
6
Framing access to essential medicines in the context of Universal Health Coverage: a critical analysis of health sector strategic plans from eight countries in the WHO African region.在全民健康覆盖背景下构建获取基本药物的途径：对世卫组织非洲区域 8 个国家卫生部门战略计划的批判性分析。
BMC Health Serv Res. 2022 Nov 22;22(1):1390. doi: 10.1186/s12913-022-08791-9.
7
Physicochemical Equivalence and Quality Assessment of Various Brands of Gastro-Resistant Omeprazole Capsules in the Kumasi Metropolis.库马西都会区各种品牌的耐胃酸奥美拉唑胶囊的理化等效性和质量评估。
ScientificWorldJournal. 2022 Nov 9;2022:7924600. doi: 10.1155/2022/7924600. eCollection 2022.
8
Multimorbidity and out-of-pocket expenditure for medicines in China and India.中、印两国的多病共存状况与药品自付费用
BMJ Glob Health. 2022 Nov;7(11). doi: 10.1136/bmjgh-2021-007724.
9
Consumers' access to information about medicine prices and availability as an enabler of last mile medicine access: A scoping review.消费者获取药品价格和可及性信息作为实现最后一公里药品可及性的推动因素：一项范围综述
J Med Access. 2022 May 15;6:27550834221098598. doi: 10.1177/27550834221098598. eCollection 2022 Jan-Dec.
10
The Impact of COVID-19 on Pharmaceutical Shortages and Supply Disruptions for Non-Communicable Diseases Among Public Hospitals of South West, Oromia, Ethiopia.2019年冠状病毒病对埃塞俄比亚奥罗米亚西南部公立医院非传染性疾病药品短缺和供应中断的影响
J Multidiscip Healthc. 2022 Aug 31;15:1933-1943. doi: 10.2147/JMDH.S377319. eCollection 2022.
本文引用的文献
1
Quality use of medicines within universal health coverage: challenges and opportunities.全民健康覆盖下的合理用药：挑战与机遇
BMC Health Serv Res. 2014 Aug 27;14:357. doi: 10.1186/1472-6963-14-357.
2
Implementation research: what it is and how to do it.实施研究：是什么以及如何开展
BMJ. 2013 Nov 20;347:f6753. doi: 10.1136/bmj.f6753.
3
Access to medicines from a health system perspective.从卫生系统角度看药品的可及性。
Health Policy Plan. 2013 Oct;28(7):692-704. doi: 10.1093/heapol/czs108. Epub 2012 Nov 22.
4
Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?在选定的发展中国家中，将品牌原研药转换为通用等效药物：可以节省多少费用？
Value Health. 2012 Jul-Aug;15(5):664-73. doi: 10.1016/j.jval.2012.04.004. Epub 2012 Jul 11.
5
Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence.医疗保险系统的药物主动管理策略，以改善中低收入国家药品的成本效益使用：当前证据的系统评价。
Health Policy. 2011 May;100(2-3):134-43. doi: 10.1016/j.healthpol.2010.10.020. Epub 2010 Dec 24.
6
Health systems financing and the path to universal coverage.卫生系统筹资与全民覆盖之路。
Bull World Health Organ. 2010 Jun;88(6):402. doi: 10.2471/BLT.10.078741.
Zotero 插件